<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02876185</url>
  </required_header>
  <id_info>
    <org_study_id>ICU_2015_39</org_study_id>
    <nct_id>NCT02876185</nct_id>
  </id_info>
  <brief_title>Evaluation of the Possibility to Delegate Glaucoma Surveillance to Orthoptists in Hospital</brief_title>
  <acronym>GLAUS</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>Fondation Ophtalmologique Adolphe de Rothschild</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fondation Ophtalmologique Adolphe de Rothschild</source>
  <brief_summary>
    <textblock>
      Glaucoma is a progressive optical neuropathy, generally associated with ocular hypertension.&#xD;
      The treatment aims to stabilize the visual field deficiencies by lowering the intraocular&#xD;
      pressure. Due to the fluctuation of the visual field test and re-test measures, the European&#xD;
      recommendations are to obtain 6 visual field tests in 2 years (or one every 4 months) in&#xD;
      order to know if the pathology is progressing despite the current treatment (or if the&#xD;
      treatment is necessary, in cases of intraocular hypertensions). The lack of ophthalmologists&#xD;
      renders the monitoring of a beginning glaucoma, rarely compatible with the present&#xD;
      recommendations. It is therefore crucial to evaluate new therapeutic alternatives, when faced&#xD;
      to a decreasing medical demography and an increase the patient's needs.&#xD;
&#xD;
      This study should allow to validate the possibility to delegate monitoring tasks to&#xD;
      orthoptists during glaucoma surveillance. To organize the delegation of this surveillance to&#xD;
      orthoptists would permit a better distribution of the ophthalmologist's activities.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">April 8, 2016</start_date>
  <completion_date type="Anticipated">April 2023</completion_date>
  <primary_completion_date type="Anticipated">April 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>detection by the orthoptists of an abnormality that would require an anticipated ophthalmologic consultation</measure>
    <time_frame>20 month of follow-up</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">133</enrollment>
  <condition>Glaucoma</condition>
  <arm_group>
    <arm_group_label>Patients with glaucoma</arm_group_label>
    <description>Patients presenting an open-angle glaucoma or ocular hypertension</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Monitoring by an orthoptist then by an ophthalmologist</intervention_name>
    <description>At each visit, the usual monitoring tests will be collected and viewed by the orthoptist then by the ophthalmologist concerning the necessity of an anticipated ophthalmological consultation</description>
    <arm_group_label>Patients with glaucoma</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patient with an open-angle glaucoma or ocular hypertension&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age from 18 years old or more&#xD;
&#xD;
          -  Open-angle glaucoma or ocular hypertension&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Other active ocular pathology&#xD;
&#xD;
          -  Monophthalmic patients&#xD;
&#xD;
          -  Patients requiring a Goldmann visual field exam&#xD;
&#xD;
          -  Opposition of the patient to participate to the trial&#xD;
&#xD;
          -  Pregnant women or breastfeeding&#xD;
&#xD;
          -  Patient under juridical protection&#xD;
&#xD;
          -  Lack of affiliation to social security or universal health coverage&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Centre hospitalier</name>
      <address>
        <city>Angers</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Ambroise-Paré</name>
      <address>
        <city>Boulogne Billancourt</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinique Universitaire d'Ophtalmologie</name>
      <address>
        <city>Grenoble</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fondation Ophtalmologique A de Rothschild</name>
      <address>
        <city>Paris</city>
        <zip>75019</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>August 16, 2016</study_first_submitted>
  <study_first_submitted_qc>August 18, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 23, 2016</study_first_posted>
  <last_update_submitted>May 21, 2021</last_update_submitted>
  <last_update_submitted_qc>May 21, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 24, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Glaucoma surveillance</keyword>
  <keyword>Orthoptist</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glaucoma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

